On

Sexual Health Research

Sydney Local Health District has the highest rates of gonorrhoea, infectious syphilis and newly diagnosed HIV in NSW, and the highest rate of chlamydia in metropolitan NSW. The District's Sexual Health Service aims to reduce the high rates of these sexually transmitted infections (STIs) in our local community and improve the health of individuals and communities living with, or at risk of, STIs, including HIV.

We are involved in a number of projects which monitor patterns of STIs, including HIV, throughout Australia. This research has led to a greater understanding of who is at highest risk of STIs and HIV and the reasons for this, allowing us to better target and plan education, prevention and clinical services for the residents of the District.

We are also involved in several collaborative studies to better understand and improve the sexual health and wellbeing of gay men, people living with HIV and other Australian populations. These include:

ACCESS (Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses) is investigating rates and risk factors for a broad range of STIs among Australians attending sexual health and other clinical services
ARCHIVE (The Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort) is monitoring and observing people living over the age of 55 for up to 10 years to evaluate differences between those living with, and without, HIV in terms of their genetic make-up and other factors associated with aging.

Our participation in two world-first clinical trials

The GoGoVax Study is a world-first study being conducted now, using a licensed meningococcal B vaccine to prove if the vaccine can also prevent gonorrhoea. Gonorrhoea (also called gono or the clap), is a global public health problem with between 87 to 106 million yearly cases, with increasing multi-drug resistance. In Australia, gonorrhoea infection rates have almost doubled over the past five years, with the most significant increase among gay, bisexual, and other men who have sex with men. People who enrol in the study receive two doses of the vaccine or the placebo over three months and then are followed for two years. At the end of the two years, everyone in the study receives the vaccine.

The Syphilaxis Study will test whether taking a daily antibiotic reduces or prevents bacterial STI acquisition in sexually active gay and bisexual men and transgender people, and whether they find taking a daily antibiotic for this purpose acceptable.

Our Research Team

Professor David Templeton	Head of Department and Head of Research
Dr Rachel Burdon	Staff Specialist
Dr Rachael Thomas	Staff Specialist
Linda Garton	Study Coordinator and Clinical Nurse Consultant
Loretta Healey	Senior Counsellor
Thomas Doyle	Study Coordinator and Clinical Nurse Specialist
Ashlee Jackson	Study Coordinator and Clinical Nurse Specialist
Dr Mary Stewart	PhD Candidate. Thesis title: Acute Sexual Assault Presentations (ASAP) study. Co-supervisor Professor David Templeton.

Selected Grants

Amount awarded	Grant and project details
$55,000	Ramsay Research Foundation, 2022-2023 Acute Sexual Assault Presentations Investigator: Stewart, M (PhD supervisor Templeton DJ)

Previous Grants

Amount awarded	Grant and project details
$10,353,045	NHMRC, 2015-2019 New interventions to control sexually transmitted infections and their consequences Associate Investigator: Templeton DJ
$105,000	Australian Postgraduate Award, 2016-2019 Informing STI and HIV testing guidelines in gay and bisexual men Investigators: Goddard SL

Our Publications

2023

Burdon RM, Atefi D, Rana J, Parasuraman A, Lee AS, Nield B. Sustained Mpox Proctitis with Primary Syphilis and HIV Seroconversion, Australia. Emerg Infect Dis. 2023 Mar;29(3):647-649. doi: 10.3201/eid2903.221845. Epub 2023 Jan 26. PMID: 36703251; PMCID: PMC9973693.

Callander D, McManus H, Gray RT, Grulich AE, Carr A, Hoy J, Donovan B, Fairley CK, Holt M, Templeton DJ, Liaw ST, McMahon JH, Asselin J, Petoumenos K, Hellard M, Pedrana A, Elliott J, Keen P, Costello J, Keane R, Kaldor J, Stoové M, Guy R. HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study. Lancet HIV. 2023 Jun;10(6):e385-e393. doi: 10.1016/S2352-3018(23)00050-4. Epub 2023 Apr 15. Erratum in: Lancet HIV. 2023 May 12;: PMID: 37068498.

Cornelisse VJ, Heath-Paynter D, Delpech V, Read P, Apostolellis A, Medland NA, MacIntyre CR, Giola M, Kidd M. How Australia and Aotearoa New Zealand avoided large-scale mpox (formerly monkeypox) outbreaks in 2022-2023. Intern Med J. 2023 Oct;53(10):1732-1738. doi: 10.1111/imj.16236. PMID: 37859543.

Cornelisse VJ, Kearley JJM, Vargas Castillo J, Macharg L, McLaughlin VA, Jack SJ, Swift C. Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines. Sex Health. 2023 Dec;20(6):585-587. doi: 10.1071/SH23139. PMID: 37852607.

Cornelisse VJ, Ong JJ, Ryder N, Ooi C, Wong A, Kenchington P, Giola M, Donovan B, Dean JA, Molina JM, Medland NA. Interim position statement on doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmissible infections in Australia and Aotearoa New Zealand - the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Sex Health. 2023 Apr;20(2):99-104. doi: 10.1071/SH23011. PMID: 36927481.

Dharan NJ, Jin F, Vaccher S, Bavinton B, Yeung B, Guy R, Carr A, Zablotska I, Amin J, Read P, Templeton DJ, Ooi C, Martin SJ, Ryder N, Smith DE, McNulty A, Brown K, Price K, Holden J, Grulich AE; Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). Clin Infect Dis. 2023 Feb 8;76(3):e622-e628. doi: 10.1093/cid/ciac660. PMID: 35982613.

Di Ciaccio PR, Van Leeuwen MT, Amin J, Vajdic CM, McGregor S, Poynten IM, Templeton DJ, Law M, Grulich AE, Polizzotto MN, Jin F. Second Primary Cancers in People With HIV/AIDS: A National Data Linkage Study of Incidence and Risk Factors. J Acquir Immune Defic Syndr. 2023 May 1;93(1):25-33. doi: 10.1097/QAI.0000000000003172. PMID: 36804500; PMCID: PMC10484748.

Gray J, Prestage G, Jin F, Phanuphak N, Friedman RK, Fairley CK, Kelleher A, Templeton DJ, Zablotska-Manos I, Hoy J, McNulty A, Baker D, Brown G, Grulich A, Bavinton B; Opposites Attract study group. Agreements, Behaviour, and Change: Sex Outside the Relationship in Male HIV-negative Partners in HIV Serodiscordant Relationships in Australia, Brazil, and Thailand. AIDS Behav. 2023 Sep;27(9):3098-3108. doi: 10.1007/s10461-023-04030-2. Epub 2023 Mar 14. PMID: 36917425; PMCID: PMC10386966.

Healey LM, Hutchinson JL, Pfeiffer MN, Garton L, Hatten B, Dobbie M, Simpson L, Templeton DJ. The challenge of providing medical follow-up for sexual assault victims: can we predict who will attend? A retrospective cross-sectional study. Sex Health. 2023 Oct;20(5):475-477. doi: 10.1071/SH22180. PMID: 37599505.

Heron JE, McManus H, Vickers T, Ryan K, Wright E, Carter A, Stoove M, Asselin J, Grulich A, Donovan B, Guy R, Varma R, Chen M, Ryder N, Lewis DA, Templeton DJ, O'Connor CC, Gracey DM; ACCESS Collaboration. Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study. PLoS One. 2023 Feb 24;18(2):e0280339. doi: 10.1371/journal.pone.0280339. PMID: 36827395; PMCID: PMC9955644.

MacGibbon J, Cornelisse VJ, Smith AKJ, Broady TR, Hammoud MA, Bavinton BR, Heath-Paynter D, Vaughan M, Wright EJ, Holt M. Mpox (monkeypox) knowledge, concern, willingness to change behaviour, and seek vaccination: results of a national cross-sectional survey. Sex Health. 2023 Oct;20(5):403-410. doi: 10.1071/SH23047. PMID: 37611539.

Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray S, Kenchington P, Moten A, Gibbs C, Maunsell S, Davis T, Michaels J, Medland NA. Australian sexually transmitted infection (STI) management guidelines for use in primary care 2022 update. Sex Health. 2023 Feb;20(1):1-8. doi: 10.1071/SH22134. PMID: 36356948.

Phillips S, Cornall AM, Molano M, Jin F, Roberts JM, Farnsworth A, Hillman RJ, Templeton DJ, Poynten IM, Garland SM, Fairley CK, Murray GL, Tabrizi SN, Grulich AE, Machalek DA. Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade Lesions. J Infect Dis. 2023 Jun 15;227(12):1407-1416. doi: 10.1093/infdis/jiac503. PMID: 36591643.

Traeger MW, Harney BL, Sacks-Davis R, van Santen DK, Cornelisse VJ, Wright EJ, Hellard ME, Doyle JS, Stoové MA. Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2023 Aug 1;10(8):ofad401. doi: 10.1093/ofid/ofad401. PMID: 37593532; PMCID: PMC10428087.

Weerasinghe MN, Ooi C, Kotsiou G, Cornelisse VJ, Painter A. Breakthrough mpox despite two-dose vaccination. Med J Aust. 2023 Oct 2;219(7):295-296. doi: 10.5694/mja2.52076. Epub 2023 Sep 3. PMID: 37660327.

2022

Amin J, Vaccher S, Templeton DJ, Bavinton B, Jin F, Zablotska I, Matthews G, Oglvie E, Yeung B, Ooi C, Dharan N, Baker DA, Read P, Grulich AE. Low prior exposure and incidence of hepatitis C in HIV negative gay and bisexual men taking PrEP: findings from the EPIC-NSW prospective implementation study. Clinical Infectious Diseases 2022;75:1497-1502.

Boettiger DC, Hamidul Huque MD, Bloch M, Woolley I, Templeton DJ, Law MG, Fraser N,. Hoy J, Petoumenos K. Physical function limitation in a cross-sectional study of gay and bisexual men with and without HIV: Findings from the Australian Positive and Peers Evaluation Study (APPLES). Sexual Health 2022;19:533-545.

Dharan N, Jin F, Vaccher S, Bavinton B, Yeung B, Guy R, Carr A, Zablotska I, Amin J, Read P, Templeton DJ, Ooi C, Martin S, Ryder N, Smith D, McNulty A, Brown K, Price K, Holden J, Grulich AE. Characteristics of HIV seroconversions in a large prospective implementation cohort study of oral HIV pre-exposure prophylaxis in men who have sex with men (EPICNSW). Clinical Infectious Diseases 2022;76: e622-e628.

IM Poynten, Jin F, Molano M, Roberts JM, Hillman RJ, Templeton DJ, Law C, Stanley MA, Waterboer T, Farnsworth A, Fairley CK, Garland SM, Grulich AE. Possible reactivation of latent anal human papillomavirus associated with markers of immune dysfunction in gay and bisexual men. Cancer Epidemiology Biomarkers and Prevention 2022;31:1052-1057.

Phillips S, Cassells K, Garland SM, Machalek DA, Roberts JM, Templeton DJ, Jin F, Poynten IM, Hillman RJ, Grulich AE, Murray GL, Tabrizi SN, Molano M, Cornall AM. Gene methylation of CADM1, MAL but not miR124 identified as a biomarker of high grade anal intraepithelial neoplasia. Scientific Reports 2022;12:3565.

Philpot SP, Aung E, Templeton DJ, Stackpool G, Varma R, Power C, Robinson S, Stratigos A, Mao L, Grulich AE, Bavinton BR. Experiences of recently HIV diagnosed gay and bisexual migrants in Australia: Implications for sexual health programs and health promotion. Health and Social Care in the Community 2022;30:e5801-e5810.

Poynten IM, Jin F, Molano Luque M, Machalek DA, Roberts JM, Hillman RJ, Cornall A, Phillips S, Templeton DJ, Law C, Fairley CK, Grulich AE, Garland SM; on behalf of the Study of Prevention of Anal Cancer Study Team. Comparison of four assays for baseline anal oncogenic human papillomavirus (HRHPV) anal detection in the Study of the Prevention of Anal Cancer (SPANC). Clinical Microbiology and Infection 2022;28:1652.e1-1652.e6.

Rees H, Callander D, Goddard SL, Griggs E, Prott G, Clifton B, Templeton DJ. Higher sexually transmissible infection test yield among men who have sex with men attending a community-based testing site compared with a clinical service in Sydney, Australia. Sexually Transmitted Diseases 2022; 49: e104-106.

Wong IKJ, Grulich AE, Poynten IM, Polizzitto M, van Leeuwen MT, Vadjic CM, Amin J, McGregor S, Law M, Templeton DJ, Jin F. Time trends in cancer incidence in Australian adults living with HIV between 1982 and 2012. HIV Medicine 2022;23:134-145.

2021

Bavinton BR, Vaccher S, Jin F, Prestage GP, Holt M, Zablotska-Manos IB, Guy R, Amin J, Templeton DJ, Yeung B, Hammoud MA, Lewis D, Baker D, Dharan N, McNulty AM, Grulich AE; for the Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group. High levels of prevention-effective adherence in the EPIC-NSW trial of HIV pre-exposure prophylaxis (PrEP). Journal of Acquired Immune Deficiency Syndromes 2021:87:1040-1047.

Chan C , Patel P, Johnson K, Vaughan M, Price K, McNulty A, Templeton DJ, Read P, Cunningham P, Grulich AE, Bavinton BR. Community-based peer-led HIV/STI testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia. AIDS 2021;35:1878-1880.

Chow EPF, Williamson DA, Hocking JS, Law MG, Maddaford K, Bradshaw CS, McNulty A, Templeton DJ, Moore R, Murray GL, Danielewski JA, Wigan R, Chen MY, Guy RJ, Zhang L, Donovan B, Grulich AE, Kaldor JM, Whiley DM, Cornelisse VJ, Howden BP, Lewis DA, Read TRH, Fairley CK. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre controlled trial. The Lancet Infectious Diseases 2021;21:647-656.

Dharan NJ, Yeh P, Bloch M, Yeung M, Baker D, Guinto J, Roth N, Ftoun S, Ognenovska K, Smith D, Hoy JF, Woolley I, Pell C, Templeton DJ, Rose N, Hutchinson J, Petoumenos K, Dawson S, Polizzotto M, Dawson MA, for the ARCHIVE Study Group. Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study. Nature Medicine 2021;27:1006-1011.

Duan Q, Carmody C, Donovan B, Guy RJ, Hui B, Kaldor JM, Lahra M, Law M, Lewis DA, Maley M, McGregor S, McNulty A, Selvey C, Templeton DJ, Whiley D, Regan D, Wood JG. Modelling outbreak response strategies for preventing spread of emergent Neisseria gonorrhoeae strains in men who have sex with men in Australia. PLoS Computational Biology 2021:4;17:e1009385.

Goddard SL, Poynten IM, Petoumenos K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Templeton DJ; on behalf of the Study of the Prevention of Anal Cancer (SPANC) Research Team. Self-reported anal symptoms and their association with anal pathology among gay and bisexual men: a cross-sectional observational analysis. Sexual Health 2021;18:123-129.

Gray J, Prestage G, Jin F, Phanuphak N, Friedman R, Fairley C, Kelleher A, Templeton DJ, Zaboltska-Manos I, Hoy J, McNulty A, Pell C, Grulich A, Bavinton B. Characteristics of agreements to have condomless anal intercourse in the presence of an undetectable viral load among HIV serodiscordant male couples in Australia, Brazil and Thailand. AIDS and Behaviour 2021;25:3944-3954.

Grulich AE, Jin F, Bavinton BR, Yeung B, Hammoud MA, Amin J, Vaccher S, Vickers T, McNulty A, Dharan NJ, Power C, Price K, Zablotska I, Baker D, Bloch M, Brown K, Carmody C, Carr A, Chaniseff D, Doong N, Finlayson R, Lewis D, Lusk J, Martin S, Ooi C, Read P, Smith D, Tuck Meng Soo C, Templeton DJ, Vlahakis E, Guy R; for the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) Research Group. Long-term protection from HIV infection in the expanded and extended EPIC-NSW study of oral HIV pre-exposure prophylaxis in gay and bisexual men. The Lancet HIV 2021;8:e486-e494.

Herbert SE, Puhr R, Petoumenos K, Lewis DA, Varma R, Couldwell DL, Law M, Templeton DJ; on behalf of the Australian HIV Observational Database (AHOD). Characteristics of Heterosexually-acquired compared to Homosexually-acquired HIV and Implications for Clinical Practice: results from the Australian HIV Observational Database. AIDS Care 2021;15:1-7.

Isaacs RA, Balendran J, Tran L, Dobbie ML, Templeton DJ. Sleep, Waking and Sleep Inertia in Sexual Assault: a retrospective descriptive study. Journal of Clinical Forensic Medicine 2021;82:102222.

Jin F, Amin J, Guy R, Vaccher S, Selvey C, Zablotska I, Holden J, Price K, Yeung B, Ogilvie E, Cabrera Quichua G, Clackett S, McNulty A, Smith D, Templeton DJ, Bavinton B, Grulich AE; on behalf of the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Adherence to daily HIV Pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia. AIDS 2021;35:1987-1996.

Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Law M, Donovan B, Philips S, Chen MY, Bradshaw CS, Boyd MA, Timms P, Chow EPF, Regan DG, McNulty A, Khaw C, Ratnayake M, Lewis DA, Kaldor J, Carvhalo N, Hocking JS, for the RTS investigators. Randomized trial of azithromycin versus doxycycline for rectal Chlamydia trachomatis. New England Journal of Medicine 2021;384:2418-27.

McManus H, Callander D, Asselin J, McMahon J, Hoy JF, Templeton DJ, Fairley CK, Donovan B, Pedrana AE, Keen P, Wilson DP, Elliott J, Kaldor J, Liaw S, Petoumenos K, Holt M, Hellard ME, Grulich AE, Carr A, Stoove MA, Guy RJ. A new method for estimating the incidence of infectious diseases. American Journal of Epidemiology 2021;190:1386-1395.

Phillips TR, Fairley CK, Donovan B, Ong JJ, McNulty A, Marshall L, Templeton DJ, Owen L, Ward A, Gunathilake M, Russell D, Langton-Lockton J, Bourne C, Martin S, Chow EPF. Sexual Health Service adaptations to the Coronavirus disease 2019 (COVID-19) pandemic in Australia: a nationwide online survey. Australia and New Zealand Journal of Public Health 2021;45:622-627.

Poynten IM, Jin F, Garland SM, Hillman RJ, Molano M, Roberts JM. Templeton DJ, Phillips S, Law C, Fairley CK, Farnsworth A, Grulich AE. HIV, immune dysfunction and the natural history of anal high-risk human papillomavirus infection in gay and bisexual men. The Journal of Infectious Diseases 2021;224:246-257.

Poynten IM, Jin F, Roberts JM, Templeton DJ, Law C, Cornall A, Molano M, Machalek DA, Carr A, Farnsworth A, Fairley CK, Garland SM, Hillman RJ, Grulich AE; on behalf of the Study of Prevention of Anal Cancer Study Team. The natural history of anal high grade squamous intraepithelial lesions in gay and bisexual men. Clinical Infectious Diseases 2021;72:853-861.

van Santen DK, Asselin J, Haber NA, Traeger MW, Callander D, Donovan B, El-Hayek C, McMahon JH, Petoumenos K, McManus H, Hoy JF, Hellard M, Guy R, Stoové M, Carr A, Elliot J, Templeton DJ, Liaw, Wilson DP. Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012-19): a longitudinal cohort study. Lancet HIV 2021;8:e623-e632.

Wong A, Rawson RV, Templeton DJ. Herpes Simplex Virus-2 (HSV-2) pseudotumour as the initial presentation of Human Immunodeficiency Virus infection. Internal Medicine Journal 2021;51:1001-100.

2020

Chan C, Patel P, Johnson K, Vaughan M, Price K, McNulty A, Templeton DJ, Read P, Cunningham P, Bavinton B. Evaluation of ACON's community-based a[TEST] HIV and STI testing services, 2015-2019 (November 2020). Available from: https://kirby.unsw.edu.au/evaluation-of-atest-2015-2019

Comninos NB, Garton LM, Guy RJ, Callander D, Fairley CK, Grulich AE, Donovan B, Goddard SL, Rutherford A, Templeton DJ; on behalf of the ACCESS collaboration. Increases in pharyngeal Neisseria gonorrhoeae positivity in men who have sex with men, 2011-2015: an observational study. Sexually Transmitted Infections 2020;96:432-435.

Cvejic E, Poynten IM, Kelly PJ, Jin F, Howard K, Grulich AE, Templeton DJ, Hillman RJ, Law C, Roberts JM, McCaffrey KJ; on behalf of the SPANC study team. Psychological and utility-based quality of life impact of screening test results for anal precancerous lesions in gay and bisexual men: baseline findings from the Study of the Prevention of Anal Cancer. Sexually Transmitted Infections 2020;96:177-183.

Goddard SL, Templeton DJ, Petoumenos K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Poynten IM; Study for the Prevention of Anal Cancer (SPANC) Research Team. Prevalence and Association of Perianal and Intra-Anal Warts with Composite High-Grade Squamous Intraepithelial Lesions Among Gay and Bisexual Men: Baseline Data from the Study of the Prevention of Anal Cancer AIDS Patient Care STDs 2020;34:436-443.

Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Boyd M, Bradshaw C, Chen MY, Donovan B, Khaw C, Lewis DA, McNulty A, Regan D, Ratnayake M, Hocking JS; on behalf of the RTS investigators. Factors associated with early resumption of condomless anal sex among men who have sex with men following rectal chlamydia treatment. Sexually Transmitted Diseases 2020;47:389-394.

Roberts JM, Poynten IM, Molano M, Machalek DA, Hillman RJ, Guzman P, Jin F, Templeton DJ, Garland SM, Grulich AE, Cornall AM. Causal human papillomavirus genotypes in anal high-grade squamous intraepithelial lesion (HSIL): anal intraepithelial neoplasia grade 2 (AIN2) and anal intraepithelial neoplasia grade 3 (AIN3) are different. Cancer Epidemiology Biomarkers and Prevention 2020;29:2078-2083.

Templeton DJ, Williamson C, Jin F, Hillman RJ, Roberts JM, Law C, Fairley CK, Garland SM, Grulich AE, Poynten IM; on behalf of the Study for the Prevention of Anal Cancer (SPANC) Research Team. Prevalence and associations of larger burden of intra-anal high-grade squamous intraepithelial lesions at baseline in an Australian cohort of gay and bisexual men: the Study of the Prevention of Anal Cancer. Cancer Epidemiology 2020;64:101661.

Wong A, Prestage GP, Poynten IM, Jin F, Hillman RJ, Law C, Fairley CK, Garland SM, Grulich AE, Templeton DJ. The impact of age on the association of recreational drug use with sexual risk behaviour: a cross-sectional observational analysis. Sexual Health 2020;17:538-542.

2019

Bavinton BR, Prestage GP, Jin F, Phanuphak N, Grinsztejn B, Fairley CK, Baker D, Hoy J, Templeton DJ. Tee BK, Kelleher A, Grulich AE, for the Opposites Attract Study Group. Strategies used by homosexual male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries. Journal of the International AIDS Society2019;22:e25277.

Blackshaw LCD, Chow EPF, Varma R, Healey L, Templeton DJ, Basu A, Turner D, Medland NA, Rix S, Fairley CK, Chen MY. The characteristics of newly arrived Asian born men who have sex with men diagnosed with HIV through sexual health services in Sydney and Melbourne, 2014-2017. Australian and New Zealand Journal of Public Health 2019;43:424-428.

Davies SC, Shapiro J, Comninos NB, Templeton DJ. Lymphogranuloma venereum presenting as penile ulcers in a two gay men without HIV infection. International Journal of STD and AIDS 2019:30:515-518.

Drak D, Barratt H, Templeton DJ, O'Connor CC, Gracey DM. Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service. PLoS One 2019;14:e0210106.

Goddard SL, Poynten IM, Petoumenous K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Templeton DJ; on behalf of the Study for the Prevention of Anal Cancer (SPANC) Research Team. Prevalence, incidence and predictors of anal Chlamydia trachomatis, anal Neisseria gonorrhoeae and syphilis among older gay and bisexual men in the longitudinal Study for the Prevention of Anal Cancer (SPANC). Sexually Transmitted Infections 2019;95:477-483.

Goddard SL, Templeton DJ, Petoumenos K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Poynten IM; on behalf of the Study for the Prevention of Anal Cancer (SPANC) Research Team. Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among gay and bisexual men: baseline data from the Study of the Prevention of Anal Cancer (SPANC). Cancer Epidemiology 2019;58:12-16.

Jin F, Vajdic CM, Law M, Amin J, van Leeuwen M, McGregor S, Poynten IM, Templeton DJ, Grulich AE. Incidence and time trends of anal cancer among people living with HIV in Australia. AIDS 2019; 33:1361-1368.

Ong JJ, Walker S, Grulich A, Hoy J, Read TRH, Bradshaw C, Chen M. Garland SM, Hillman R, Templeton DJ, Hocking J. Eu B, Tee BK, Chow EPF, Fairley CK. Incidence, clearance and persistence of anal HPV in men who have sex with men living with HIV: implications for HPV vaccination. Sexually Transmitted Diseases 2019;46:229-233.

Puhr R, Petoumenos K, Huang R, Templeton DJ, Woolley I, Bloch M, Russell D, Law M, Cooper DA. Cardiovascular disease and diabetes in HIV-positive and -negative gay and bisexual men over the age of 55 years in Australia: insights from the APPLES study. HIV Medicine 2019;20:121-130.

Vaccher SJ, Marzinke MA, Templeton DJ, Haire BG, Ryder N, McNulty A, Foster R, Grulich AE, Zablotska IB. Predictors of daily adherence to HIV pre-exposure prophylaxis in gay/bisexual men in the PRELUDE Demonstration Project. AIDS and Behaviour 2019;23:1287-1296.

Ward J, Guy RJ, Rumbold AR, McGregor S, Wand H, McManus H, Dyda A, Garton L, Hengel B, Silver BJ, Taylor-Thomson D, Knox J, Donovan B, Law M, Maher L, Fairley CK, Skov S, Ryder N, Moore E, Mein J, Reeve C, Ah Chee D, Boffa J, Kaldor JM; STRIVE investigators. Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trial. Lancet Global Health 2019;7::e1553-e1563.

Zablotska IB, Vaccher SJ, Bloch M, Carr A, Foster R, Grulich AE, Guy R, McNulty A, Ooi C, Pell C, Poynten IM, Prestage G, Ryder N, Templeton D; on behalf of the PrELUDE study group. High adherence to HIV pre-exposure prophylaxis and no HIV seroconversions despite high levels of risk behaviour and STIs: the Australian demonstration study PrELUDE. AIDS and Behaviour 2019; 23:1780-1789.

Our Presentations

2023

Callander D, Cook T, Asselin J, Templeton DJ, Menon A, Meng Soo CT, Wilcox J, Bell C, Fairley CK, Stoove M, Hellard M, Cornelisse V, Guy R, Donovan B. Decreasing incidence of HIV but more variable increasing and stable incidence of sexually transmissible infections among trans and gender non-binary people in Australia: a 10-year national study. AusPath Conference 2023, Melbourne.

Huang Z, Lim YL, Thomas R, Sharp N. A new intrauterine device (IUD) service for targeted vulnerable populations groups in a publicly funded sexual health service in Sydney, NSW. Australasian Sexual and Reproductive Health Conference 2023, Sydney.

Jiamsakul A, Rupasinghe D, Woolley I, Choi JY, Templeton DJ, Widhani A, Petoumenos K, Tanuma J, on behalf of the TREAT Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific. HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD). Asia-Pacific AIDS & Co-Infections Conference 2023, Singapore.

Jin F, Poynten IM, Hillman RJ, Law C, Molano Luque M, Fairley CK, Garland SM, Templeton DJ, Grulich AE, Roberts J; on behalf of the SPANC study team. The potential role of reflex anal cytology testing in anal cancer screening using human papillomavirus (HPV) testing in gay and bisexual men. International Anal Neoplasia Conference 2023, Puerto Rico.

Molano M, Machalek DA, Roberts JM, Murray G, Law C, Poynten IM, Cornall A, Templeton DJ, Hillman RJ, Haqshenas G, Guzman P, Phillips S, Grulich AE, Garland SM, Jin F, on behalf of The SPANC Study Team. Characteristics of confirmed persistent and non-persistent anal high-grade squamous intraepithelial lesions in gay and bisexual men. 35th International Papillomavirus Conference 2023, Washington DC, USA.

Molano M, Machalek DA, Roberts JM, Murray G, Law C, Poynten IM, Cornall A, Templeton DJ, Hillman RJ, Haqshenas G, Guzman P, Phillips S, Grulich AE, Garland SM, Jin F, on behalf of The SPANC Study Team. Does CADM1, MAL AND miR124-2 host dna methylation from anal swabs predict lesion grade and persistence? 35th International Papillomavirus Conference 2023, Washington DC, USA.

2022

2021

Chow EPF, Williamson DA, Hocking JS, Law MG, Maddaford K, Bradshaw CS, McNulty A, Templeton DJ, Moore R, Murray GL, Danielewski JA, Wigan R, Chen MY, Guy RJ, Zhang L, Donovan B, Grulich AE, Kaldor JM, Whiley DM, Cornelisse VJ, Howden BP, Lewis DA, Read TRH, Fairley CK. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre controlled trial. Australasian HIV Conference, online, Nov 2021.

Gibson M, Fong G, Herbert Chan H, Templeton DJ, Chen A, Lowe PM. An exophytic penile mass. Australasian College of Dermatology Annual Scientific Meeting 2021, Virtual.

Grulich AE, Jin F, Bavinton BR, Yeung B, Hammoud MA, Amin J, Vaccher S, Vickers T, McNulty A, Dharan NJ, Power C, Price K, Zablotska I, Baker D, Bloch M, Brown K, Carmody C, Carr A, Chaniseff D, Doong N, Finlayson R, Lewis D, Lusk J, Martin S, Ooi C, Read P, Smith D, Tuck Meng Soo C, Templeton DJ, Vlahakis E, Guy R; for the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) Research Group. Long-term protection from HIV infection in the expanded and extended EPIC-NSW study of oral HIV pre-exposure prophylaxis in gay and bisexual men. Australasian HIV Conference 2021, Virtual.

Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Law M, Donovan B, Philips S, Chen MY, Bradshaw CS, Boyd MA, Timms P, Chow EPF, Regan DG, McNulty A, Khaw C, Ratnayake M, Lewis DA, Kaldor J, Carvhalo N, Hocking JS, for the RTS investigators. Treatment efficacy of 1g azithromycin versus 100mg doxycycline bi-daily for seven days for asymptomatic rectal Chlamydia trachomatis. World STI/HIV Congress 2021, Virtual.

Lau A, Kong FYS, Fairley CK, Templeton DJ, Amin J, Law M, Donovan B, Philips S, Chen MY, Bradshaw CS, Boyd MA, Timms P, Chow EPF, Regan DG, McNulty A, Khaw C, Ratnayake M, Lewis DA, Kaldor J, Carvhalo N, Hocking JS, for the RTS investigators. Treatment efficacy of 1g azithromycin versus 100mg doxycycline bi-daily for seven days for asymptomatic rectal Chlamydia trachomatis. Australasian Sexual Health Conference 2021, Virtual.

Phillips T, Fairley CK, Hocking J, Maddaford K, McNulty A, Lewis DA, Templeton DJ, Ward A, Marshall L, Powyer S, Staniszewski J, Donovan B, Chow EPF. Differences in number of sexual partners among gay and bisexual men who have sex with men before and after the covid-19 pandemic: a repeated cross-sectional survey. Australasian Sexual Health Conference, online, Nov 2021.

Phillips TR, Fairley CK, Donovan B, Ong JJ, McNulty A, Marshall L, Templeton DJ, Owen L , Ward A , Gunathilake M, Russell D, Langton-Lockton J1, Bourne C, Chow EPF. Sexual Health Service adaptations to the Coronavirus Disease 2019 (Covid-19) Pandemic in Australia: A Nationwide Online Survey. Australasian Sexual Health Conference, online, Nov 2021.

Romero A, Dailey B, Kao S-C, Sheils S, Pritchard-Jones J, Templeton D, Murray C, McNulty A, Cunningham P. Non-clinical service provision of HIV and Hepatitis C dried blood spot testing in community settings. International Conference on Hepatitis Care in Substance Users 2021, Virtual.

Romero A, Dailey B, Kao SC, Sheils S, Pritchard-Jones J, Templeton DJ. Success of a non-clinical service offering HIV and Hepatitis C Dried Blood Spot Testing in the community. 12th Australasian Viral Hepatitis Conference 2021, Virtual.

2020

Templeton DJ, Jin F, Poynten IM, Hillman RJ, Roberts JM, Law C, Balasubramanian S, Fairley CK, Garland SM, Grulich AE; on behalf of the Study of Prevention of Anal Cancer Study Team Prevalence and predictors of loss to follow-up of gay and bisexual men (GBM) in the longitudinal Study of the Prevention of Anal Cancer (SPANC). International Papillomavirus Conference, Barcelona, Spain, March 2020.

Callander DJ , Stoové M, McManus H, Carr A, Gray R, Hoy J, Donovan B, Hellard M, Grulich AE, Fairley CK, Holt M, Templeton DJ, Liaw T, McMahon J, Guy RJ;, for the TAIPAN Advisory Group. Decreasing community viremia is associated with decreasing HIV incidence in Australia. Conference on Retroviruses and Opportunistic Infections (CROI), Boston, US, March 2020.

Chan C, Johnson K, Patel, P, Vaughan M, Templeton DJ, Read P, McNulty A, El-Hayek C, Bavinton BR. Community-Based HIV/STI Testing is effective at reaching Priority Populations In New South Wales: An Evaluation of a[TEST]. Australasian HIV Conference, online, Nov 2020.

Chow EPF, Williamson DA, Hocking JS, Law MG, Maddaford K, Bradshaw CS, McNulty A, Templeton DJ, Moore R, Murray GL, Danielewski JA, Wigan R, Chen MY, Guy RJ, Zhang L, Donovan B, Grulich AE, Kaldor JM, Whiley DM, Cornelisse VJ, Howden BP, Lewis DA, Read TRH, Fairley CK. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre controlled trial. 2020 STD Prevention Conference, Atlanta, US.

Chow EPF, Williamson DA, Hocking JS, Law MG, Maddaford K, Bradshaw CS, McNulty A, Templeton DJ, Moore R, Murray GL, Danielewski JA, Wigan R, Chen MY, Guy RJ, Zhang L, Donovan B, Grulich AE, Kaldor JM, Whiley DM, Cornelisse VJ, Howden BP, Lewis DA, Read TRH, Fairley CK. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre controlled trial. Australasian HIV Conference, online, Nov 2020.

Molano-Luque M , Roberts JM, Machalek DA, Garland SM, Templeton DJ, Jin F, Poynten IM, Hillman RJ, Law C, Guzman P, Turner R, Simpson S, Grulich AE, Tabrizi SN, Cornall AM; on behalf of The SPANC Study Team. Lesion-based estimates of human papillomavirus (HPV) prevalence in anal high-grade squamous intrapithelial lesions (HSIL) stratified by lesion grade and HIV status in gay and bisexual men (GBM): The Study of the Prevention of Anal Cancer. International Papillomavirus Conference, Barcelona, Spain, March 2020.

Phillips TR, Fairley CK, Donovan B, Ong JJ, McNulty A, Marshall L, Templeton DJ, Owen L , Ward A , Gunathilake M, Russell D, Langton-Lockton J1, Bourne C, Chow EPF. Sexual Health Service adaptations to the Coronavirus Disease 2019 (Covid-19) Pandemic in Australia: A Nationwide Online Survey. Australasian Sexual Health Conference, online, Nov 2020.

Phillips TR, Fairley CK, Hocking J, Maddaford K, McNulty A, Lewis DA, Templeton DJ, Ward A, Marshall L, Powyer S, Staniszewski J, Donovan B, Chow EPF. Differences in number of sexual partners among gay and bisexual men who have sex with men before and after the covid-19 pandemic: a repeated cross-sectional survey. Australasian Sexual Health Conference, online, Nov 2020.

Wong I, Poynten IM, Cornall A, Templeton DJ, Molano-Luque M, Garland SM, Fairley CK, Law C, Hillman R, Polizzotto M. Grulich AE, Jin F. Sexual behaviours associated with incident high risk anal HPV infection among gay and bisexual men: results from the Study of the Prevention of Anal Cancer. International Papillomavirus Conference, Barcelona, Spain, March 2020.

2019

Bavinton B, Vaccher S, Holt M, Guy R, Prestage G, Jin F, Amin J, Templeton DJ, Selvey C, Zablotska-Manos I, Lusk J, Ogilvie E, Vickers T , Smith D, Grulich A. Use of condoms for the prevention of STIs among HIV PrEP users. STI and HIV World Congress 2019, Vancouver, Canada, July 2019.

Bavinton B, Vaccher S, Prestage G, Holt M, Amin J, Guy R, Selvey C, Zablotska-Manos I, Carr A, Templeton DJ, Vlahakis E, Bloch M, Baker D, Grulich A, The Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Condomless anal intercourse and adequacy of protection from HIV PrEP in the EPIC-NSW trial. 10th International AIDS Society Conference on HIV Science, Mexico City, Mexico, July 2019.

Bavinton B, Vaccher S, Prestage G, Holt M, Guy R, Amin J, Selvey C, Zablotska-Manos I, Carr A, Templeton DJ, Grulich A, The Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. Factors associated with stopping PrEP for 3 months or more in the EPIC-NSW. 10th International AIDS Society Conference on HIV Science, Mexico City, Mexico, July 2019.

Cornelisse VJ, Medland NA, Read P, Bourne C, Varma R, Templeton DJ. Australian Sexually Transmissible Infection and HIV testing guidelines for asymptomatic men who have sex with men 2019: a systematic review of the evidence. Australasian Sexual Health Conference, Perth, Australia, September 2019.

Garton L, Field E, Wand H, Guy R, Vickers T, Callander D, Donovan B, Templeton DJ, on behalf of the ACCESS collaboration. Routine treatment of Chlamydia and Gonorrhoea sexual contacts attending Sexual Heath Services: is immediate treatment necessary? Australasian Sexual Health Conference, Perth, Australia, September 2019.

Goddard SL, Poynten IM, Petoumenos K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Templeton DJ; on behalf of the Study of the Prevention of Anal Cancer (SPANC) Research Team. Prevalence and predictors of self-reported anal symptoms among gay and bisexual men at baseline in the longitudinal Study of the Prevention of Anal Cancer (SPANC). International Anal Neoplasia Society Annual Meeting, Amsterdam, The Netherlands, November 2019.

Hillman R, Comben S, Jin F, Roberts J, Law C, Templeton DJ, Fleming G, Carr A, Grulich AE, Poynten IM. Risk stratification used to optimise follow up of people at high risk of anal cancer. International Anal Neoplasia Society Annual Meeting, Amsterdam, The Netherlands, November 2019.

Poynten IM, Dan L, Jin F, Molano M, Machalek D, Roberts J, Hillman RJ, Templeton DJ, Law C, Fairley CK, Garland SM, Grulich AE, Cornall A; on behalf of the Study of Prevention of Anal Cancer Study Team. Comparison of four assays for baseline anal high-risk Human Papillomavirus (HRHPV) detection in the Study of the Prevention of Anal Cancer (SPANC). International Anal Neoplasia Society Annual Meeting, Amsterdam, The Netherlands, November 2019.

Templeton DJ, Jin F, Poynten IM, Hillman RJ, Roberts JM, Law C, Balasubramanian S, Fairley CK, Garland SM, Grulich AE; on behalf of the Study of Prevention of Anal Cancer Study Team. Prevalence and predictors of loss to follow-up of gay and bisexual men (GBM) in the longitudinal Study for the Prevention of Anal Cancer (SPANC). International Anal Neoplasia Society Annual Meeting, Amsterdam, The Netherlands, November 2019.

Templeton DJ, Poynten IM, Jin F, Roberts JM, Law CLH, Cornall AM, Molano M, Machalek DA, Carr A, Farnsworth A, Tabrizi S, Phillips S , Fairley CK, Garland SM, Hillman RJ, Grulich AE; on behalf of the Study of Prevention of Anal Cancer Study Team. The natural history of anal high grade squamous Intraepithelial lesions in HIV positive and HIV negative gay and bisexual men. 17th European AIDS Conference, Basel, Switzerland, November 2019 (Oral)

Templeton, DJ. Invited speaker. HPV vaccination in MSM: who should be vaccinated and is there a role for vaccination of older and/or HIV-positive MSM in preventing initial, persistent and recurrent HPV and related diseases?International Society for Sexually Transmitted Diseases Research World Congress, Vancouver

Vaccher S, Guy R, Templeton DJ, Zablotska-Manos I, Clackett S, Holt M, Prestage G, Amin J, Selvey C, Jin F, Grulich AE, Bavinton B. PrEP use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial. STI and HIV World Congress 2019, Vancouver, Canada, July 2019 (Poster)

Vaccher S, Holt M, Prestage G, Amin J, Selvey C, Zablotska-Manos I, Guy R, Jin F, Templeton DJ, Carr A, Bloch M, Baker D, Vlahakis E, Grulich A, Bavinton B, The Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group. High levels of HIV PrEP adherence among methamphetamine users in the EPIC-NSW trial. 10th International AIDS Society Conference on HIV Science, Mexico City, Mexico, July 2019 (Poster)

Wong A, Poynten IM, Jin F, Hillman RJ, Prestage G,Fairley CK, Garland SM, Garton L, Grulich AE, Templeton DJ; on behalf of the Study for the Prevention of Anal Cancer (SPANC) Research Team. Recreational drug use and associations with sexual behaviour among older gay & bisexual men at baseline in the longitudinal Study for the Prevention of Anal Cancer (SPANC). Australasian Sexual Health Conference, Perth, Australia, September 2019 (Poster)

Sexual Health Research

Our participation in two world-first clinical trials

Our Research Team

Selected Grants

Our Publications

2023

Our Presentations

2023

Sexual Health Research

Sexual Health Research

Our Organisation

Make a Donation

Our Hospitals

Right to Information

Plans

Publications

Quick Links